243 related articles for article (PubMed ID: 23306212)
1. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.
Lai YH; Yu SL; Chen HY; Wang CC; Chen HW; Chen JJ
Carcinogenesis; 2013 May; 34(5):1069-80. PubMed ID: 23306212
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
3. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.
Wang CC; Lin SY; Lai YH; Liu YJ; Hsu YL; Chen JJ
PLoS One; 2012; 7(4):e33772. PubMed ID: 22529897
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
Chen HW; Lee JY; Huang JY; Wang CC; Chen WJ; Su SF; Huang CW; Ho CC; Chen JJ; Tsai MF; Yu SL; Yang PC
Cancer Res; 2008 Sep; 68(18):7428-38. PubMed ID: 18794131
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.
Wang CC; Tsai MF; Hong TM; Chang GC; Chen CY; Yang WM; Chen JJ; Yang PC
Oncogene; 2005 Jun; 24(25):4081-93. PubMed ID: 15782117
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates.
Yan H; Zhu Y; Liu B; Wu H; Li Y; Wu X; Zhou Q; Xu K
Br J Nutr; 2011 Dec; 106(12):1779-91. PubMed ID: 21733335
[TBL] [Abstract][Full Text] [Related]
11. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
[TBL] [Abstract][Full Text] [Related]
12. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
[TBL] [Abstract][Full Text] [Related]
13. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles.
Kumar VB; Yuan TC; Liou JW; Yang CJ; Sung PJ; Weng CF
Mutat Res; 2011 Feb; 707(1-2):42-52. PubMed ID: 21185843
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer.
Lim JC; Chan TK; Ng DS; Sagineedu SR; Stanslas J; Wong WS
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):300-10. PubMed ID: 22017767
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
[TBL] [Abstract][Full Text] [Related]
20. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]